The Irreversible FGFR Inhibitor KIN-3248 Overcomes FGFR2 Kinase Domain MutationsEranga R. Balasooriya, Nabeel Bardeesy|Clinical Cancer Research|2024Cited by 14
Integrating Clinical Cancer and PTM Proteomics Data Identifies a Mechanism of ACK1 Kinase ActivationEranga R. Balasooriya, Joshua L. Andersen|Molecular Cancer Research|2023Cited by 2